N.J. dental students accused of cheating

May 17, 2006

New Jersey's only dental school is investigating allegations that 18 students traded or sold clinical procedure credits they need to graduate, a report said.

The New Jersey Dental School cheating scandal came to light when students who had not met their required number of clinical procedures to graduate complained about classmates' alleged wrongdoing.

"It's cheating and it's outright wrong," Dean Cecile Feldman told the Newark (N.J.) Star Ledger.

"It's not a majority of the class, but it is sizable," she said of the 18 students suspected out of 84 who are supposed to graduate Sunday.

Penalties range from repeating clinical dental work to outright dismissal, Feldman said.

The cheating scandal is the latest woe to hit the University of Medicine and Dentistry of New Jersey, and could cost the dental school and the university its accreditation, the newspaper reported.

The Newark university already is under a federal monitor for alleged corruption and is the focus of an ongoing criminal investigation.

Copyright 2006 by United Press International

Explore further: School scoliosis screening has sustained effectiveness

Related Stories

We must defend science if we want a prosperous future

Mar 03, 2015

Today's Australians are, by far, the best educated cohort in our history –- on paper, anyway -– but this is not reflected in the quality of our political discourse. We appear to be lacking in courage, ...

Recommended for you

Bacteria blamed in indigenous Mexican baby deaths

6 hours ago

Bacteria—and not a contaminated vaccine as initially suspected—were to blame for the recent deaths of two Mexican babies and for sickening 29 others, according to an official investigation.

German woman, 65, gives birth to quadruplets

6 hours ago

A 65-year-old teacher from Berlin has given birth to quadruplets after a pregnancy that was widely criticized by medical professionals because of her age, RTL television said Saturday.

US appeals court upholds delay in Alzheimer's drug swap

22 hours ago

A federal appeals court has rejected a drug manufacturer's appeal and affirmed a judge's order that Actavis PLC keep distributing its widely used Alzheimer's medication until after its patent expires this summer.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.